Billiontoone, Inc. $BLLN Shares Bought by Emerald Mutual Fund Advisers Trust

Emerald Mutual Fund Advisers Trust raised its holdings in Billiontoone, Inc. (NASDAQ:BLLN) by 11.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 132,206 shares of the company’s stock after purchasing an additional 14,072 shares during the quarter. Emerald Mutual Fund Advisers Trust’s holdings in Billiontoone were worth $10,436,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Rossby Financial LCC acquired a new position in shares of Billiontoone in the 4th quarter valued at about $25,000. Wells Fargo & Company MN purchased a new stake in shares of Billiontoone in the fourth quarter worth about $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone during the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in Billiontoone during the fourth quarter valued at approximately $82,000. Finally, Renaissance Capital LLC purchased a new position in Billiontoone during the fourth quarter valued at approximately $201,000.

Billiontoone Stock Performance

Shares of BLLN stock opened at $123.25 on Tuesday. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18. Billiontoone, Inc. has a 12-month low of $61.96 and a 12-month high of $138.70. The business’s 50 day moving average is $101.46 and its two-hundred day moving average is $89.09. The company has a market capitalization of $5.67 billion and a P/E ratio of 224.09.

Billiontoone (NASDAQ:BLLN) last announced its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.33. The business had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. During the same period in the previous year, the company earned ($0.39) earnings per share. The company’s quarterly revenue was up 83.8% compared to the same quarter last year. Analysts expect that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Nancy Joann Johnson sold 801 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $124.91, for a total value of $100,052.91. Following the completion of the sale, the insider owned 21,099 shares of the company’s stock, valued at approximately $2,635,476.09. The trade was a 3.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of the company’s stock in a transaction on Thursday, July 9th. The stock was sold at an average price of $125.00, for a total transaction of $1,000,000.00. Following the transaction, the insider owned 204,000 shares of the company’s stock, valued at $25,500,000. This represents a 3.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 153,049 shares of company stock worth $16,768,021 in the last 90 days.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Guggenheim began coverage on shares of Billiontoone in a research note on Monday, June 29th. They set a “buy” rating and a $125.00 price objective on the stock. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. JPMorgan Chase & Co. raised their price target on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Finally, BTIG Research cut their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $126.00.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.